Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vivos Therapeutics Inc (NQ: VVOS )

0.3502 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 17, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 261
Open 0.3502
Bid (Size) 0.3502 (1)
Ask (Size) 0.3622 (7)
Prev. Close 0.3502
Today's Range 0.3502 - 0.3502
52wk Range 0.3015 - 2.962
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Participate at 35th Annual ROTH Conference
Via Investor Brand Network
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch... 
Via Benzinga

Performance

YTD
-52.68%
-52.68%
1 Month
-55.67%
-55.67%
3 Month
-24.59%
-24.59%
6 Month
-68.16%
-68.16%
1 Year
-86.63%
-86.63%

More News

Read More
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Vivos Therapeutics Shares Are Nosediving
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Expands Product Portfolio, Revenue Potential Through Strategic Acquisition
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation at Emerging Growth Conference
Via Investor Brand Network
7 Micro-Cap Stocks to Buy for Risk-Taking Investors
Via InvestorPlace
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Regains Compliance with Nasdaq Listing Requirements
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Closing of $8M Private Placement
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Enters into Private Placement Agreement
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Via Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Dow Gains 150 Points After Fed Minutes
Via Benzinga
Micron News: Why Is MU Stock Up Today?
Via InvestorPlace
6 Things to Know About Atlis Motor Vehicles as AMV Stock Surges Today
Via InvestorPlace
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The Sleep Apnea News That Has VVOS Stock Soaring Today
Via InvestorPlace
Nasdaq Rises Over 100 Points; Crude Oil Drops Sharply
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces FDA Clearance of Proprietary Oral Appliance for Obstructive Sleep Apnea Treatment
Via Investor Brand Network
Exposures Product Safety
Why Vivos Therapeutics (VVOS) Shares Are Skyrocketing Wednesday
Via Benzinga
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.